The expiration date for this activity has been extended and the activity was re-released on January 19, 2017.
1.00 / AMA PRA Category 1 Credit(s)TM
Provided by EXCEL Continuing Education
Supported by GE Healthcare
Accurate mammograms are limited in dense breasts where surrounding fibroglandular tissue decreases the view of lesions. Even when tumors are detected, the full extent of the disease may not be clearly visible. New advances in breast imaging technologies include the use of contrast-enhanced spectral mammography, a safe and effective screening tool for the potential detection and diagnosis of cancerous lesions. This is part 3 in a series of 5 independent 1 hour accredited activities that will discuss the use of this screening tool in clinical practice as it compares to other imaging technologies.
Radiologists, breast imaging specialists, radiation oncologists, surgical oncologists, breast cancer oncologists, fellows, residents, and other healthcare professionals who care for patients with breast cancer.
At the conclusion of this activity, participants should be able to:
Identify CEM characteristics for infiltrating lobular (ILC), infiltrating ductal carcinoma (IDC), and DCIS
Recognize clumped enhancement and nodular regional enhancement of DCIS
Diagnose benign lesions including cysts and fibroadenomas through CEM
Review logistics when assessing benign and malignant lesions on CEM
Conflict Of Interest Disclosure Policy
EXCEL Continuing Education requires all those who are in a position to control the content of this activity including faculty, planners, peer reviewers, and EXCEL staff to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to EXCEL policy.
The existence or absence of COI for anyone in a position to control content is disclosed below:
Dr. Geetika Klevos, MD, peer reviewer, has no relevant financial information to disclose. EXCEL staff have no relevant financial information to disclose.
Lydia Liao, MD, PhD, MPH Director of Cooper Breast Imaging Centers MD Anderson-Cooper Cancer Institute Professor of Radiology Cooper Medical School of Rowan University Camden, NJ
Dr. Lydia Liao, MD, presenter, has indicated that she has received honoaria as a speaker for GE Healthcare and Devicor Medical.
AMA PRA Category 1 Credit(s)TM
EXCEL Continuing Education is accredited by the Accrediation Council for Continuing Medical Education to provide continuing medical education for physicians.
EXCEL Continuing Education designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. European physicians can earn their EACCMEC®s by completing e-learning programs from accredited providers from the United States that have been certified for AMA PRA Category 1 CreditTM. For more information, go to http://www.uems.eu/uems-activities/accreditation/eaccme.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.
For questions regarding this activity, please contact EXCEL Continuing Education at firstname.lastname@example.org or phone (305) 630-9414.